TY - JOUR
T1 - Simultaneous quantification of the 22-kDa isoforms of human growth hormone 1 and 2 in human plasma by multiplexed immunocapture and LC-MS/MS
AU - Sleumer, Bas
AU - van Faassen, Martijn
AU - Vos, Michel J.
AU - den Besten, Gijs
AU - Kema, Ido P.
AU - van de Merbel, Nico C.
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/2/1
Y1 - 2024/2/1
N2 - An LC-MS/MS method is presented for the simultaneous quantification of two structurally closely related protein biomarker isoforms, the 22-kDa isoforms of human growth hormone 1 and human growth hormone 2, in human plasma. It is based on multiplexed immunocapture using two monoclonal antibodies immobilized on magnetic beads, tryptic digestion and quantification of two specific signature peptides plus an additional peptide for estimation of total growth hormone related concentrations. A full validation according to international guidelines was performed across the clinically relevant concentration ranges of 0.5 to 50 ng/mL for growth hormone 1, and 2 to 50 ng/mL for growth hormone 2 and demonstrated satisfactory method performance in terms of accuracy, precision, stability and absence of interference. The method's applicability for routine analysis and its ability to effectively distinguish between GH1 and GH2 was demonstrated by the analysis of plasma samples from pregnant individuals to study the changes in growth hormone levels during pregnancy.
AB - An LC-MS/MS method is presented for the simultaneous quantification of two structurally closely related protein biomarker isoforms, the 22-kDa isoforms of human growth hormone 1 and human growth hormone 2, in human plasma. It is based on multiplexed immunocapture using two monoclonal antibodies immobilized on magnetic beads, tryptic digestion and quantification of two specific signature peptides plus an additional peptide for estimation of total growth hormone related concentrations. A full validation according to international guidelines was performed across the clinically relevant concentration ranges of 0.5 to 50 ng/mL for growth hormone 1, and 2 to 50 ng/mL for growth hormone 2 and demonstrated satisfactory method performance in terms of accuracy, precision, stability and absence of interference. The method's applicability for routine analysis and its ability to effectively distinguish between GH1 and GH2 was demonstrated by the analysis of plasma samples from pregnant individuals to study the changes in growth hormone levels during pregnancy.
KW - Biomarker
KW - Human growth hormone 1
KW - Human growth hormone 2
KW - Immunocapture
KW - Isoform
KW - Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
UR - http://www.scopus.com/inward/record.url?scp=85182455202&partnerID=8YFLogxK
U2 - 10.1016/j.cca.2023.117736
DO - 10.1016/j.cca.2023.117736
M3 - Article
C2 - 38142804
AN - SCOPUS:85182455202
SN - 0009-8981
VL - 554
JO - Clinica chimica acta
JF - Clinica chimica acta
M1 - 117736
ER -